Position | Company | Period |
---|
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-01-10 | 2024-01-09 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
11 271
-6.7%
4,3849 367 USD |
11 271 -6.7% | 4,38 | 49 367 USD | |
2023-01-11 | 2023-01-10 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
10 917
-6.1%
5,2457 205 USD |
10 917 -6.1% | 5,24 | 57 205 USD | |
2022-01-13 | 2022-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
418
-0.3%
49,1220 532 USD |
418 -0.3% | 49,12 | 20 532 USD | |
2022-01-13 | 2022-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
4 152
-2.7%
48,44201 123 USD |
4 152 -2.7% | 48,44 | 201 123 USD | |
2022-01-12 | 2022-01-10 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
351
-0.2%
47,1716 557 USD |
351 -0.2% | 47,17 | 16 557 USD | |
2022-01-12 | 2022-01-10 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
5 245
-3.3%
46,33243 001 USD |
5 245 -3.3% | 46,33 | 243 001 USD | |
2021-12-14 | 2021-12-13 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
1 600
-1.0%
49,2778 832 USD |
1 600 -1.0% | 49,27 | 78 832 USD | |
2021-12-14 | 2021-12-13 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
7 718
-4.6%
48,75376 253 USD |
7 718 -4.6% | 48,75 | 376 253 USD | |
2021-12-14 | 2021-12-13 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
6 564
-3.8%
47,61312 512 USD |
6 564 -3.8% | 47,61 | 312 512 USD | |
2021-12-14 | 2021-12-13 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
7 018
-3.9%
46,72327 881 USD |
7 018 -3.9% | 46,72 | 327 881 USD | |
2021-12-14 | 2021-12-13 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
2 100
-1.2%
45,6895 928 USD |
2 100 -1.2% | 45,68 | 95 928 USD | |
2021-09-14 | 2021-09-13 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
800
-0.8%
67,4653 965 USD |
800 -0.8% | 67,46 | 53 965 USD | |
2021-09-14 | 2021-09-13 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
8 391
-8.0%
66,84560 879 USD |
8 391 -8.0% | 66,84 | 560 879 USD | |
2021-09-14 | 2021-09-13 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
15 809
-13.1%
65,941 042 414 USD |
15 809 -13.1% | 65,94 | 1 042 414 USD | |
2021-06-16 | 2021-06-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
400
-0.4%
90,7636 303 USD |
400 -0.4% | 90,76 | 36 303 USD | |
2021-06-16 | 2021-06-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
8 220
-7.9%
89,68737 155 USD |
8 220 -7.9% | 89,68 | 737 155 USD | |
2021-06-16 | 2021-06-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
16 380
-13.6%
89,111 459 587 USD |
16 380 -13.6% | 89,11 | 1 459 587 USD | |
2021-03-16 | 2021-03-15 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
1 018
-1.1%
94,5996 297 USD |
1 018 -1.1% | 94,59 | 96 297 USD | |
2021-03-16 | 2021-03-15 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
3 205
-3.2%
93,75300 461 USD |
3 205 -3.2% | 93,75 | 300 461 USD | |
2021-03-16 | 2021-03-15 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
8 404
-7.8%
92,64778 578 USD |
8 404 -7.8% | 92,64 | 778 578 USD | |
2021-03-16 | 2021-03-15 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
8 416
-7.2%
91,94773 782 USD |
8 416 -7.2% | 91,94 | 773 782 USD | |
2021-03-16 | 2021-03-15 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
3 957
-3.3%
90,89359 654 USD |
3 957 -3.3% | 90,89 | 359 654 USD | |
2021-01-12 | 2021-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
871
-1.1%
109,6595 509 USD |
871 -1.1% | 109,65 | 95 509 USD | |
2021-01-12 | 2021-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
1 051
-1.3%
110,76116 407 USD |
1 051 -1.3% | 110,76 | 116 407 USD | |
2021-01-12 | 2021-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
1 332
-1.6%
111,62148 673 USD |
1 332 -1.6% | 111,62 | 148 673 USD | |
2021-01-12 | 2021-01-08 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
151
-0.2%
114,7617 328 USD |
151 -0.2% | 114,76 | 17 328 USD | |
2021-01-12 | 2021-01-08 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
872
-1.1%
115,80100 977 USD |
872 -1.1% | 115,80 | 100 977 USD | |
2021-01-12 | 2021-01-08 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
2 451
-2.9%
117,15287 144 USD |
2 451 -2.9% | 117,15 | 287 144 USD | |
2021-01-12 | 2021-01-08 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
2 756
-3.2%
117,60324 103 USD |
2 756 -3.2% | 117,60 | 324 103 USD | |
2020-12-15 | 2020-12-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
100
-0.1%
102,7510 275 USD |
100 -0.1% | 102,75 | 10 275 USD | |
2020-12-15 | 2020-12-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
1 006
-1.1%
102,06102 675 USD |
1 006 -1.1% | 102,06 | 102 675 USD | |
2020-12-15 | 2020-12-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
400
-0.5%
100,9740 388 USD |
400 -0.5% | 100,97 | 40 388 USD | |
2020-12-15 | 2020-12-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
3 822
-4.1%
99,77381 315 USD |
3 822 -4.1% | 99,77 | 381 315 USD | |
2020-12-15 | 2020-12-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
3 148
-3.3%
98,80311 013 USD |
3 148 -3.3% | 98,80 | 311 013 USD | |
2020-12-15 | 2020-12-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
2 946
-3.0%
97,70287 812 USD |
2 946 -3.0% | 97,70 | 287 812 USD | |
2020-12-15 | 2020-12-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
11 765
-10.7%
96,651 137 141 USD |
11 765 -10.7% | 96,65 | 1 137 141 USD | |
2020-12-15 | 2020-12-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
1 813
-1.6%
95,89173 857 USD |
1 813 -1.6% | 95,89 | 173 857 USD | |
2020-09-16 | 2020-09-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
600
-0.7%
37,4922 494 USD |
600 -0.7% | 37,49 | 22 494 USD | |
2020-09-16 | 2020-09-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
7 016
-7.4%
36,93259 085 USD |
7 016 -7.4% | 36,93 | 259 085 USD | |
2020-09-16 | 2020-09-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
16 784
-15.0%
36,03604 654 USD |
16 784 -15.0% | 36,03 | 604 654 USD | |
2020-09-16 | 2020-09-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
600
-0.5%
34,6520 792 USD |
600 -0.5% | 34,65 | 20 792 USD | |
2020-01-10 | 2020-01-08 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
5 700
-6.2%
20,69117 947 USD |
5 700 -6.2% | 20,69 | 117 947 USD | |
2019-10-16 | 2019-10-15 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
6 200
-8.5%
14,1887 891 USD |
6 200 -8.5% | 14,18 | 87 891 USD |